HomeLIXT • NASDAQ
Lixte Biotechnology Holdings Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 613.50K | -40.20% |
Net income | -617.69K | 40.16% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.04M | -75.28% |
Total assets | 1.15M | -73.41% |
Total liabilities | 318.28K | 1.41% |
Total equity | 827.22K | — |
Shares outstanding | 2.68M | — |
Price to book | -0.95 | — |
Return on assets | -107.96% | — |
Return on capital | -139.80% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -617.69K | 40.16% |
Cash from operations | -598.68K | 33.64% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -598.68K | 33.64% |
Free cash flow | -374.12K | 27.69% |
Previous close
$1.13
Year range
$1.02 - $3.65
Market cap
2.95M USD
Avg Volume
27.19K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2005
Website
Employees
2
